TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.